The American Academy of Pain Management
The American Academy of Pain Management is an inclusive, interdisciplinary, and integrative organization serving clinicians who treat people with pain through education, setting standards of care, and advocacy.
The American Academy of Pain Management News and Research is made possible, in part, by educational grants from the following sponsers:
Clinical Trials
Alabama
Arthritis
City: Anniston
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Birmingham
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Mobile
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Arizona
Analgesics, Opioid
City: Phoenix
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Tucson
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Arkansas
Arthritis
City: Little Rock
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
California
Arthritis
City: Burbank
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Carlsbad
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Fair Oaks
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Long Beach
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Norwalk
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Pomona
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Roseville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Sacramento
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: San Diego
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: San Marino
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Santa Ana
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Tustin
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Vista
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: West Covina
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Connecticut
Analgesics, Opioid
City: Trumbull
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Danbury
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
District of Columbia
Neck Pain
City: Washington
Summary: A study to determine whether interventional treatment (i.e. epidural steroids), conservative therapy, or the combination, is superior for cervical radiculopathy.
Florida
Analgesics, Opioid
City: Clearwater
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Coral Gables
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Deland
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Pembroke Pines
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Plantation
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Tamarac
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Clearwater
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Gainesville
Summary: A study to determine the safety and tolerability of two different formulations of BMP-7 for the treatment of osteoarthritis of the knee.
City: Jupiter
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Pembroke Pines
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Pinellas Park
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Tampa
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Back Pain
City: Ormond Beach
Summary: A study to evaluate the efficacy, safety, and tolerability of a new medication for chronic low back pain.
Neck Pain
City: Altamonte Springs
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Jacksonville
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Kissimmee
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Lake Mary
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Orange Park
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Orlando
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
City: Oviedo
Summary: A project to develop a prediction rule to identify which patients with neck pain have a greater probability of benefiting from a standardized program of education and exercise.
Nervous System Diseases
City: St. Petersburg
Summary: A study to investigate the effects of a medication on individuals with neuropathic pain due to an episode of shingles, an accident, or surgical procedures in the past.
Pancreatitis
City: Gainesville
Summary: A study to determine whether the addition of Nexium to Viokase 16 will decrease chronic abdominal pain in patients with small duct chronic pancreatitis in a superior fashion compared to Viokase 16 plus placebo or to Nexium alone.
Georgia
Arthritis
City: Atlanta
Summary: A clinical research study to evaluate the safety and effectiveness of an investigational drug to see if it can provide relief from pain caused by arthritis.
City: Decatur
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: East Point
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Idaho
Arthritis
City: Boise
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Illinois
Arthritis
City: Springfield
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Indiana
Analgesics, Opioid
City: Evansville
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Terre Haute
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Kansas
Arthritis
City: Overland Park
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Topeka
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Wichita
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Kentucky
Analgesics, Opioid
City: Crestview Heights
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Louisiana
Arthritis
City: Baton Rouge
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Lafayette
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Metairie
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Monroe
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Shreveport
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Maryland
Arthritis
City: Wheaton
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Neck Pain
City: Baltimore
Summary: A study to determine whether interventional treatment (i.e. epidural steroids), conservative therapy, or the combination, is superior for cervical radiculopathy.
Massachusetts
Arthritis
City: Boston
Summary: A study to determine the safety and tolerability of two different formulations of BMP-7 for the treatment of osteoarthritis of the knee.
City: Waltham
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Nervous System Diseases
City: Boston
Summary: A study investigating the mechanisms of transcranial direct current stimulation of the motor cortex for the treatment of chronic pain in spinal cord injury.
City: Boston
Summary: A study to better understand how the spinal cord stimulator (SCS) relieves chronic pain in patients who already have a spinal cord stimulator in place.
Pelvic Pain
City: Boston
Summary: A study seeking chronic pelvic pain patients for research on therapy with brain stimulation.
Michigan
Analgesics, Opioid
City: Kalamazoo
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Clarkston
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Flint
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Grand Rapids
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Troy
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Urologic Diseases
City: Royal Oak
Summary: A study assessing chronic pain conditions in patients with and without interstitial cystitis.
Mississippi
Arthritis
City: ww
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Missouri
Back Pain
City: Saint Louis
Summary: A study examining the muscle characteristics and skeletal alignment in people with and without lower back pain using MRI (magnetic resonance imaging).
Montana
Arthritis
City: Missoula
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Nebraska
Arthritis
City: Omaha
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Breast Diseases
City: Lincoln
Summary: A research study seeks females who suffer from moderate to severe breast pain associated with their menstrual cycle.
Nevada
Arthritis
City: Las Vegas
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
New Jersey
Arthritis
City: Freehold
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: New Brunswick
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
New York
Acupuncture Analgesia
City: Bronx
Summary: A project to evaluate the addition of acupuncture to the management of chronic pain in ethnically diverse, low-income primary care patients with osteoarthritis, back, or neck pain.
Arthritis
City: Brooklyn
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Nervous System Diseases
City: Staten Island
Summary: A study evaluating the effects of persistent pain on neuropsychological functioning and how it applies to community integration with patients that have had a traumatic brain injury.
Pain /therapy (general)
City: New York
Summary: Adults with moderate to severe chronic pain are asked to participate in a research study.
North Carolina
Analgesics, Opioid
City: Charlotte
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: High Point
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
City: Winston-Salem
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Charlotte
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Hickory
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Shelby
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Ohio
Arthritis
City: Columbus
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Willoughby Hills
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Youngstown
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Oklahoma
Arthritis
City: Oklahoma City
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Pennsylvania
Arthritis
City: Duncansville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Philadelphia
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Headache Disorders
City: Philadelphia
Summary: A study to evaluate blood levels of several proteins that may be altered in the inflammation associated with migraine headaches.
Rhode Island
Arthritis
City: Cumberland
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
South Carolina
Arthritis
City: Charleston
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Columbia
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Greenville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Varnville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Tennessee
Analgesics, Opioid
City: Memphis
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Bristol
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Clarksville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Jackson
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Johnson City
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Texas
Analgesics, Opioid
City: Austin
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Arthritis
City: Austin
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Houston
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Lake Jackson
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Leander
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Nassau Bay
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: North Richard Hills
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: San Antonio
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Utah
Analgesics, Opioid
City: Salt Lake City
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.
Virginia
Arthritis
City: Danville
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
City: Newport News
Summary: A study to collect additional data on patients who have completed the core study CACZ885H2357 to support the registration of canakinumab for the indication of gout.
Washington
Headache Disorders
City: Seattle
Summary: A study to examine an investigational drug for the treatment of menstrually-related migraines.
Wisconsin
Analgesics, Opioid
City: New Berlin
Summary: A study evaluating the long-term safety and tolerability of the buprenorphine transdermal delivery system in subjects with chronic nonmalignant pain syndromes whose pain has been previously controlled by oral opioid combination therapy.